Pneumonia in HIV-infected patients: A case-control survey of factors involved in risk and prevention

AIDS

Volumn 13, Issue 14, 1999, Pages 1971-1975

  Guerrero, Mario ^a,c   Kruger, Sally ^a   Saitoh, Akihiko ^a   Sorvillo, Frank ^b   Cheng, Kai Jen ^b   French, Carolyn ^a   Beall, Gildon ^a  

^a HARBOR UCLA MEDICAL CENTER   (United States)

^b HIV Epidemiology Program   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Drug users; Opportunistic infections; Pneumococcal vaccine; Vaccine

Indexed keywords

INFLUENZA VACCINE; PNEUMOCOCCUS VACCINE;

ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNIZATION; INFECTION PREVENTION; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; PNEUMONIA; PRIORITY JOURNAL; RISK FACTOR;

ADOLESCENT; ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; DATABASES, FACTUAL; FEMALE; HUMANS; MALE; MIDDLE AGED; PNEUMONIA, PNEUMOCYSTIS; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 0032736386     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-199910010-00021     Document Type: Article

References (17)

1. Polsky B, Gold JWM, Whimbey E, Dryjanski J, Brown AE, Schiffman G, Armstrong D. Bacterial pneumonia in patients with the acquired immunodeficiency syndrome. Ann Intern Med 1986, 104:38-41.
2. Janoff EN, Breiman RF, Daley CL, Hopewell P. Pneumococcal disease during HIV infection. Ann Intern Med 1992, 117:314-321.
3. Selwyn PA, Feingold AR, Martel D, et al. Increased risk of bacterial pneumonia in HIV-infected intravenous drug users without AIDS. AIDS 1988, 2:267-272.
4. Boschini A, Smacchia C, Di Fine M, et al. Community-acquired pneumonia in a cohort of former injection drug users with and without human immunodeficiency virus infection: incidence, etiologies, and clinical aspects. Clin Infect Dis 1996, 23:107-113.
5. USPHS. Guidelines for the prevention of opportunistic infections in person infected with human immunodeficiency virus: a summary. MMWR 1999, 48:(RR-10):1-59.
6. Gallant JE, Moore RD, Chaisson RE. Prophylaxis for opportunistic infections in patients with HIV infection. Ann Intern Med 1994, 120:932-944.
7. Demaurex N, Gabriel V, Auckenthaler R, Demaurex F, Hirschel B. The efficacy of pneumococcal vaccination in HIV seropositive patients (HIV+): a case control study. VIIIth International Conference on AIDS/III STD World Congress. Amsterdam, July 1992 [Abstract PoB 3890].
8. Hardy WD, Feinberg J, Finkelstein DM, et al. A controlled trial of trimethoprim-sulfamethoxazole or aerosolized pentamidine for secondary prophylaxis of Pneumocystis carinii pneumonia in patients with the acquired immunodeficiency syndrome. N Engl J Med 1992, 327:1842-1848.
9. Podzamczer D, Salazar A, Jimenez J, et al. Intermittent trimethoprim-sulfamethoxazole compared with dapsonepyrimethamine for the simultaneous primary prophylaxis of pneumocystis pneumonia and toxoplasmosis in patients infected with HIV. Ann Intern Med 1995, 122:755-761.
10. Wortley PM, Farizo KM. Pneumococcal and influenza vaccination levels among HIV-infected adolescents and adults receiving medical care in the United States. AIDS 1994, 8:941-944.
11. Brichacek B, Swindells S, Janoff EN, et al. Increased plasma human immunodeficiency virus type 1 burden following antigenie challenge with pneumococcal vaccine. J Infect Dis 1996, 174:1191-1199.
12. Janoff EN, Fasching C, Ojoo JC, et al. Responsiveness of human immunodeficiency virus type 1-infected Kenyan women with or without prior pneumococcal disease to pneumococcal vaccine. J Infect Dis 1997, 175:975-978.
13. Kroon FP, van Dissel JT, de Jong JC, van Furth R. Antibody response to influenza, tetanus and pneumococcal vaccines in HIV-seropositive individuals in relation to the number of CD4+ lymphocytes. AIDS 1994, 8:469-476.
14. 2 response to pneumovax in HIV seropositive patients. Cenitourin Med 1993, 69:373-376.
15. Mickey MR, Greenland S. A study of the impact of confounder-selection criteria on effect estimation. Am J Epidemiol 1989, 129:125-137.
16. Rothman K, Greenland S. Modern epidemiology. Philadelphia: Lippincott-Raven Publishers; 1998.
17. Greenland S. Modeling and variable selection in epidemiologic analysis. Am J Public Health 1989, 79:340-349.